| Name: | Capecitabine 3-O-BDR Impurity |
| Catalogue No. | VE007562 |
| CAS No. | 1262133-64-1 |
| Molecular Formula | C20H30FN3O9 |
| Molecular Weight | 475.47 g/mol |
| Status | In-Stock |
| IUPAC Name | 2′,3′-Di-O-acetyl-5′-deoxy-5-fluorocytidine ; 3-O-(5-Deoxy-β-D-ribofuranosyl) Capecitabine |
| Description | Capecitabine 3-O-BDR Impurity (CAS No: 1262133-64-1) Or 2′,3′-Di-O-acetyl-5′-deoxy-5-fluorocytidine ; 3-O-(5-Deoxy-β-D-ribofuranosyl) Capecitabine,Capecitabine 3-O-BDR is an impurity of Capecitabine,which is used for the treatment of breast,colorectal, gastric, and esophageal cancers. |
| References | Sci-Hub | Ultrasound-assisted dispersive solid-phase microextraction of capecitabine by multi-stimuli responsive molecularly imprinted polymer modified with chitosan nanoparticles followed by HPLC analysis | 10.1007/s00604-020-04345-0. (2020). Retrieved January 2, 2022, from Sci-hub.ee website: https://sci-hub.ee/10.1007/s00604-020-04345-0 |
